Submissions

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

The manuscript is original, has not previously been published, and is not currently under consideration by another journal.
The manuscript falls within the Aims and Scope of the Indonesian Journal of Augmented Medical Intelligence.
The manuscript has been prepared according to the IJAMI Author Guidelines and the applicable manuscript template.
The anonymized manuscript does not contain author names, affiliations, acknowledgments, institutional identifiers, document properties, or other information that could reveal the authors’ identities.
A separate title page has been uploaded containing the article title, author names, affiliations, ORCID iDs, corresponding-author details, funding information, conflicts of interest, word count, and CRediT contribution statements.
The manuscript includes all mandatory statements applicable to the study, including funding, conflicts of interest, data availability, ethics approval, informed consent, authors’ contributions, and generative-AI use.
Research involving human participants, identifiable patient information, animals, or protected health data includes the necessary ethics approval and consent documentation.
The relevant reporting guideline checklist has been completed and uploaded as a supplementary file, where applicable.
Manuscripts involving artificial intelligence, machine learning, prediction models, or generative AI comply with the IJAMI AI-Methods Reporting Policy.
Tables are provided in editable form, figures meet the journal’s resolution requirements, and permission has been obtained for all third-party material.
DOIs or stable URLs have been included for references wherever available, and the reference list follows APA 7th edition.
All authors have reviewed and approved the submitted manuscript and agree to the journal’s Copyright Notice and CC BY 4.0 licensing terms.

Author Guidelines

IJAMI — Author Guidelines

1. Before You Submit

Before preparing your manuscript, please read:

The journal’s Aims & Scope to confirm fit.
The AI-Methods Reporting Policy (mandatory for any manuscript involving machine learning, prediction models, or generative AI).
The Submission Preparation Checklist (you will be asked to confirm each item during submission).
The Copyright Notice and Licensing Terms (CC-BY 4.0).

2. Manuscript Types

IJAMI publishes six article types. Choose the section that matches your manuscript.

Section	Peer-reviewed	Abstract	Word limit (excl. references)
Editorial	Editor-reviewed	None	1,500 – 2,500
Original Research	Yes (anonymous)	Structured, ≤250 words	4,000 – 6,000
Review	Yes	Unstructured, ≤250 words	5,000 – 8,000
Implementation Report	Yes	Structured: Setting / Intervention / Outcome / Lessons, ≤300 words	3,000 – 5,000
Perspective	Editor-reviewed	None	2,000 – 3,000
Case Report	Yes	Unstructured, ≤200 words	1,500 – 2,500

Implementation Report is IJAMI’s signature format. We particularly welcome reports describing real-world deployment of augmented intelligence tools in clinical settings, including studies of adoption barriers, workflow integration, and lessons from implementations that did not achieve their stated outcomes.

3. Manuscript Preparation

3.1 Language

Manuscripts must be submitted in British English. Authors whose first language is not English are encouraged to use a professional language-editing service before submission. Inadequate language quality is grounds for desk rejection.

3.2 Format

File format: Microsoft Word (.docx) or LaTeX (PDF + source).
Body text: Times New Roman, 12 pt, 1.5 line spacing, justified.
Headings: Arial bold, hierarchical (H1, H2, H3).
Margins:5 cm on all sides.
Line numbers: continuous throughout the manuscript (mandatory).
Page numbers: bottom-right.

3.3 Structure

For Original Research and Implementation Reports, follow IMRaD:

Title page (separate file — see §3.4)
Abstract + Keywords
Introduction
Methods
Results
Discussion
Conclusion
Acknowledgments
Declaration of Interests
Funding
Data Availability Statement
Authors’ Contributions (CRediT)
References
Tables
Figure legends
Figures (uploaded as separate files)

3.4 Title Page (anonymized submissions)

Submit the title page as a separate file to preserve anonymity for double-anonymous review (Original Research). Include:

Full title (≤150 characters including space)
Short running title (≤50 characters)
All authors’ full names
ORCID iD for every author
Institutional affiliations with ROR identifier (rorinstitute.org)
Corresponding author’s email and ORCID
Word count (excluding references)
Number of tables and figures
Conflict-of-interest statement
Funding statement (with FundRef IDs where applicable)
CRediT contribution roles for each author

3.5 Abstract and Keywords

Word limit per article type (see §2).
Keywords: 3–6 terms, drawn from MeSH (Medical Subject Headings) where possible.
For Original Research and Implementation Reports, structured abstracts are required.

3.6 References

Citation style: APA 7th edition. In-text citations use author–year format (e.g., Lee et al., 2023). The reference list is alphabetized by first author’s surname.

DOIs are mandatory for every reference that has one.
Journal names are italicized, in full (no abbreviations).
Volume number italicized; issue number in parentheses.
For preprints, cite the repository (e.g., medRxiv, arXiv) with DOI and version.

Authors are responsible for the accuracy of references. We strongly recommend using a reference manager (Zotero, Mendeley, EndNote) with the APA 7 style file.

3.7 Tables and Figures

Tables: editable text format inside the manuscript (not images). Numbered consecutively. Each table must have a title and footnotes for abbreviations.
Figures: uploaded as separate files. Minimum 300 dpi. TIFF, PNG, or vector (SVG, PDF, EPS). Color figures are free of charge.
Figure legends collated at the end of the manuscript, before the figures themselves.
All non-original figures require explicit reproduction permission from the rights holder attached at submission.

4. Mandatory Statements

The following must appear in every manuscript:

4.1 Declaration of Interests

All authors must declare any financial or non-financial interests that could be perceived to bias the work, following ICMJE guidance. State “None” only if truly applicable.

4.2 Funding

State all sources of funding, including grant numbers and FundRef IDs. State “None” if the work received no specific funding.

4.3 Data Availability Statement

A statement is mandatory for all original research. Use one of:

“The data that support the findings of this study are openly available in [repository] at [DOI/URL].”
“The data are available from the corresponding author upon reasonable request, subject to [conditions].”
“The data are not publicly available because [specific reason — e.g., participant privacy under local IRB approval].”

For LMIC-context studies, IJAMI recognizes legitimate data sovereignty concerns. Restrictions must be justified, not assumed.

4.4 Ethics Approval and Consent

For research involving human participants: - State the IRB/Research Ethics Committee name, location, and approval reference number. - Confirm informed consent was obtained (or explain waiver). - For studies using de-identified retrospective data, state the IRB determination. - Adhere to the Declaration of Helsinki (most recent revision).

4.5 Authors’ Contributions (CRediT)

Use the CRediT taxonomy (credit.niso.org). Each author must be assigned at least one role from: Conceptualization, Methodology, Software, Validation, Formal analysis, Investigation, Resources, Data curation, Writing – original draft, Writing – review and editing, Visualization, Supervision, Project administration, Funding acquisition.

4.6 AI Use Disclosure

Mandatory for any manuscript that used generative AI tools (large language models, image generators, etc.) at any stage. See the AI-Methods Reporting Policy for the full statement format. AI tools are not authors and cannot be credited as such (ICMJE).

5. Reporting Standards

Manuscripts involving the following study designs must include the corresponding completed reporting checklist as a supplementary file:

Study type	Required checklist
Clinical trial of an AI intervention	CONSORT-AI
Clinical trial protocol involving AI	SPIRIT-AI
Diagnostic / prognostic prediction model	TRIPOD-AI
Early-stage clinical evaluation of AI	DECIDE-AI
AI study reporting minimum information	MI-CLAIM
Systematic review	PRISMA 2020
Observational study	STROBE
Qualitative research	SRQR or COREQ
Case report	CARE

Submissions without an applicable checklist are returned to the author before peer review.

6. Submission Process

Submission is online through the IJAMI OJS portal. The corresponding author must provide a valid ORCID iD. Authors are strongly encouraged to authenticate their ORCID through the journal’s ORCID integration when this functionality is available.

Required upload files:

Title page (separate, with all identifying information)
Anonymized manuscript (no author names, affiliations, or self-identifying language)
Figures (one file per figure)
Reporting checklist (where applicable)
Ethics approval letter (where applicable)
Permission letters for reproduced material (where applicable)
Supplementary files (where applicable)

7. Peer Review

IJAMI uses double-anonymous peer review for Original Research and single-anonymous review (reviewer identity hidden, author identity disclosed) for Reviews, Implementation Reports, and Case Reports. Editorial and Perspective submissions are editor-reviewed.

Initial editorial decision: within 14 days of submission.
Reviewer response deadline: 7 days.
Review completion deadline: 21 days.
Authors receive the editor’s decision with reviewer comments. Revision deadlines are set by the handling editor.

A dedicated Statistical Editor reviews methodology and statistical claims for Original Research papers involving prediction models or comparative effectiveness analyses.

8. Publication

Accepted articles will be published in PDF format on the IJAMI website. Each article will have an individual article landing page containing complete bibliographic metadata. Additional HTML and machine-readable formats may be introduced as the journal’s production infrastructure develops. Digital Object Identifiers will be assigned and registered through the publisher’s approved Crossref arrangement.

Authors receive proof for review. Proof corrections are limited to typesetting errors; substantive changes require Editor approval.

9. Article Processing Charges (APCs)

For Volumes 1 and 2 (Year 1), no APC is charged. IJAMI is subsidized by Universitas Udayana / JUPI during this period to remove financial barriers from inaugural authors. APC policy from Volume 3 onwards will be announced no later than six months in advance and will include APC waivers for authors from low-income countries and corresponding authors without grant funding.

10. Copyright and Licensing

Authors retain copyright. Articles are published under a Creative Commons Attribution 4.0 International (CC-BY 4.0) license, allowing unrestricted use, distribution, and reproduction with appropriate attribution.

11. Self-Archiving

Authors may deposit any version of their manuscript (preprint, accepted manuscript, or published version) in any repository at any time, with no embargo. We encourage deposit of preprints (medRxiv, arXiv) and notification of the editor if a preprint exists at submission.

12. Complaints and Appeals

Authors may appeal editorial decisions in writing to the Editor-in-Chief within 30 days of the decision. Complaints regarding editorial process or publication ethics are handled in accordance with COPE flowcharts.

13. Contact

Editorial Office: ijamiudayana@unud.ac.id
Technical Support: ijamiudayana@unud.ac.id

Original Research

Original Research articles report complete, methodologically rigorous investigations that make a substantive contribution to augmented intelligence in medicine, artificial intelligence in healthcare, digital health, medical informatics, clinical decision support, medical imaging, prediction modelling, or related fields within the journal’s scope.

Suitable submissions include clinical prediction-model studies, diagnostic or prognostic accuracy studies, evaluations of AI-assisted clinical decision support, randomized or non-randomized clinical studies, observational studies, medical-imaging studies, natural-language-processing studies, human–AI collaboration research, health-information-system evaluations, fairness and bias studies, and real-world validation of healthcare technologies.

Pure algorithm-development studies without a clearly articulated clinical application, appropriate validation, or meaningful healthcare context are not suitable.

Original Research manuscripts must normally follow the IMRaD structure: Introduction, Methods, Results, Discussion, and Conclusion. A structured abstract of no more than 250 words is required.

Submissions must include all applicable statements concerning ethics approval, informed consent, clinical-trial registration, funding, conflicts of interest, data availability, CRediT authorship contributions, and use of generative artificial intelligence.

Manuscripts involving artificial intelligence, machine learning, prediction models, or generative AI must comply with the IJAMI AI-Methods Reporting Policy and must include the applicable reporting checklist.

Original Research manuscripts undergo double-anonymous peer review. Authors must upload a separate title page and an anonymized manuscript that does not contain author names, affiliations, acknowledgments, institutional identifiers, document properties, or other identifying information.

Each manuscript will normally be assessed by at least two independent reviewers. Manuscripts involving advanced statistics, prediction models, comparative-effectiveness analysis, or AI methodology may also be evaluated by a Statistical Editor or AI/Technical Editor.

Review

Review articles critically synthesize and evaluate existing evidence relevant to augmented intelligence, artificial intelligence in healthcare, digital health, medical informatics, clinical technology, and related fields.

IJAMI considers systematic reviews, meta-analyses, scoping reviews, umbrella reviews, evidence maps, rapid reviews, methodological reviews, state-of-the-art reviews, and selected narrative reviews.

Systematic and scoping reviews must use transparent and reproducible methods. Authors must describe the review question, eligibility criteria, information sources, search strategy, study-selection process, data-extraction procedures, risk-of-bias assessment, synthesis methods, and limitations.

Systematic reviews and meta-analyses must follow PRISMA 2020 or another applicable reporting guideline. Scoping reviews should follow PRISMA-ScR. Protocol registration in PROSPERO or another recognised registry is strongly encouraged where applicable.

Narrative reviews must provide a balanced, critical, and evidence-based synthesis. Authors must explain how the literature was identified and selected.

Reviews of AI or machine-learning studies should assess dataset representativeness, external validation, risk of bias, subgroup performance, fairness, reproducibility, clinical utility, human oversight, and implementation feasibility where relevant.

Review manuscripts undergo single-anonymous peer review. Reviewer identities are concealed from the authors, while author identities are available to reviewers. Each manuscript will normally be evaluated by at least two reviewers with relevant subject or evidence-synthesis expertise.

Implementation Report

Implementation Reports describe the real-world introduction, adaptation, evaluation, scaling, or discontinuation of augmented-intelligence, artificial-intelligence, digital-health, or health-information technologies in clinical and healthcare environments.

Implementation Reports are a signature IJAMI article format. The journal particularly welcomes reports from Southeast Asia, low- and middle-income countries, resource-constrained healthcare settings, rural and remote services, and tropical-medicine contexts.

Suitable submissions include implementation of clinical decision-support systems, AI-assisted diagnostic services, electronic health records, telemedicine, mobile health, remote monitoring, connected-health programmes, clinician or patient adoption, organisational readiness, workflow integration, change management, training, implementation costs, human factors, usability, safety monitoring, implementation failure, unintended consequences, and transition from pilot projects to routine clinical use.

The journal welcomes both successful and unsuccessful implementations, provided that the report presents transparent, evidence-based, and transferable lessons. Implementation Reports must not be promotional descriptions of commercial products or institutional programmes.

The manuscript should describe the setting, implementation need, intervention or technology, implementation strategy, stakeholder involvement, workflow integration, evaluation methods, outcomes, barriers and facilitators, safety and ethical considerations, lessons learned, sustainability, and scalability.

A structured abstract of no more than 300 words is required, using the headings: Setting, Intervention, Outcome, and Lessons.

Authors should use an appropriate implementation-science framework where applicable. Reports involving artificial intelligence or machine learning must comply with the IJAMI AI-Methods Reporting Policy.

Implementation Reports undergo single-anonymous peer review. Reviewer identities are concealed from authors, while author identities and institutional settings are available to reviewers because implementation context is essential to evaluation.

Each submission will normally be reviewed by at least two reviewers whose combined expertise covers the relevant clinical domain and implementation science, health services, digital health, or medical informatics. An AI/Technical Editor may be assigned where applicable.

Perspective

Perspective articles present a focused, scholarly, and evidence-informed viewpoint on an emerging issue, unresolved problem, conceptual development, ethical question, policy challenge, or future direction within the journal’s scope.

Suitable topics include human oversight of clinical AI, responsible AI governance, algorithmic fairness, health equity, data sovereignty, regulation of medical AI, AI implementation in low-resource settings, clinical accountability, patient perspectives, workforce preparation, methodological controversies, research priorities, tropical-medicine technology, and regional priorities for Southeast Asia.

Perspective articles should present a clear central argument supported by relevant evidence. Authors should acknowledge significant alternative viewpoints and clearly distinguish established evidence from interpretation, opinion, or proposal.

Perspective articles are not intended to report original research findings, provide systematic evidence synthesis, promote commercial products, publish institutional publicity, or present unsupported personal opinion.

Perspective submissions are reviewed internally by the Editor-in-Chief or a designated Section Editor. The editor evaluates relevance, originality, timeliness, quality of argument, appropriate use of evidence, consideration of competing viewpoints, ethical appropriateness, and conflicts of interest.

External expert advice may be obtained when the topic is highly technical, controversial, or outside the immediate expertise of the Editorial Board. Such consultation does not classify the article as externally peer reviewed.

Case Report

Case Reports describe clinically important, unusual, educational, or previously underreported cases involving augmented intelligence, artificial intelligence, digital health, connected medical technology, or clinical decision-support systems.

Suitable submissions may include an unexpected benefit or failure of an AI system, a clinically significant false-positive or false-negative result, human–AI disagreement affecting clinical management, algorithmic bias affecting a patient or population, a technology-related adverse event, an unusual application of clinical decision support, or a case demonstrating the importance of clinician oversight.

A Case Report must provide a clear educational contribution and must not merely describe use of a technology.

Case Reports should follow the CARE reporting guideline. Authors must upload a completed CARE checklist as a supplementary file.

The manuscript should normally include an Introduction, Patient Information, Clinical Findings, Timeline, Diagnostic Assessment, Technology or AI Involvement, Clinical Intervention, Outcome and Follow-up, Discussion, Patient Perspective where appropriate, Conclusion, and Informed-Consent Statement.

The report must clearly explain the intended function of the technology, how its output was interpreted, the role of the responsible clinician, whether the recommendation was followed or overridden, how the technology influenced care, and the generalisable clinical or patient-safety lesson.

Written informed consent for publication must be obtained from the patient or the patient’s legally authorised representative. Consent must cover publication of identifiable clinical information or images under the journal’s open-access licence. Authors must remove unnecessary identifying information.

Case Reports undergo single-anonymous peer review. Reviewer identities are concealed from authors, while author identities are available to reviewers.

Each manuscript will normally be reviewed by at least one relevant clinical specialist and, where applicable, one reviewer with expertise in artificial intelligence, digital health, informatics, ethics, or patient safety.

Copyright Notice

Authors who publish in the Indonesian Journal of Augmented Medical Intelligence retain copyright in their work. By submitting and publishing with IJAMI, authors grant the journal and its publisher a non-exclusive licence to publish, distribute, archive and preserve the article in print, electronic and machine-readable formats.

All IJAMI articles are published under the Creative Commons Attribution 4.0 International licence. This licence permits sharing and adaptation of the work for any purpose, including commercial use, provided that appropriate credit is given to the original author or authors, a link to the licence is provided, and any changes are indicated.

Authors remain responsible for obtaining permission for third-party copyrighted material included in their article. The Creative Commons licence applies only to original material published under that licence and does not override separate rights notices attached to third-party content.

Privacy Statement

Effective date: [insert effective date]
Last updated: [insert revision date]

The Indonesian Journal of Augmented Medical Intelligence (IJAMI), published by Universitas Udayana through the Unit Jurnal dan Publikasi Ilmiah (JUPI), is committed to protecting the privacy and personal data of authors, reviewers, editors, readers, and other users of the journal website.

This Privacy Statement explains how personal data are collected, used, stored, disclosed, and protected through the IJAMI website, the Open Journal Systems platform, email communications, and the journal’s submission, peer-review, editorial, production, and publication processes.

1. Personal Data We Collect

IJAMI may collect and process the following categories of personal data.

Account and profile information

Full name
Username
Email address
Password in encrypted or otherwise protected form
Institutional affiliation
Department or organisation
Country
Mailing address, where provided
Telephone number, where provided
ORCID iD
Personal or institutional website
Academic interests and reviewing expertise
Languages
User roles, such as author, reviewer, editor, or reader

Manuscript and editorial information

Manuscript title, abstract, keywords, and subject classification
Names, affiliations, email addresses, and ORCID iDs of authors and contributors
Authorship and CRediT contribution statements
Funding information
Conflict-of-interest declarations
Ethics approval and informed-consent statements
Data-availability statements
Generative-AI use disclosures
Manuscripts, figures, tables, reporting checklists, supplementary files, and related documentation
Editorial correspondence
Reviewer invitations and responses
Peer-review reports
Editorial decisions
Copyediting, production, and proofreading records

Technical and usage information

The OJS platform and its supporting systems may automatically process technical information such as:

Internet Protocol address
Browser and device information
Date and time of access
Login and account activity
Pages visited
Referring website
Download and usage statistics
System logs
Cookies or similar technologies required for authentication, navigation, security, and website functionality

2. Purposes of Data Processing

Personal data may be processed for the following purposes:

Creating and managing user accounts
Receiving and administering manuscript submissions
Conducting editorial screening and peer review
Communicating with authors, reviewers, editors, and other contributors
Assigning editorial and reviewing responsibilities
Copyediting, producing, publishing, correcting, and preserving scholarly content
Verifying authorship, affiliation, ORCID information, disclosures, and research-integrity requirements
Investigating complaints, appeals, corrections, retractions, or suspected publication misconduct
Maintaining the integrity and security of the journal platform
Generating journal-management and usage statistics
Improving the website and editorial workflow
Registering and disseminating publication metadata
Depositing metadata with DOI registration agencies, indexing services, repositories, libraries, preservation services, and scholarly discovery systems
Complying with applicable legal, regulatory, institutional, contractual, and research-integrity obligations

Personal data will not be sold, rented, or used for unrelated commercial marketing.

3. Publication of Personal Information

Information associated with an accepted and published article becomes part of the permanent scholarly record.

The following information may be made publicly available:

Author names
Institutional affiliations
Country
ORCID iDs
Corresponding-author contact information
Authorship-contribution statements
Funding statements
Conflict-of-interest declarations
Ethics and consent statements
Data-availability statements
Generative-AI use disclosures
Article metadata and citation information

Authors are responsible for ensuring that the personal information of all co-authors and contributors is accurate and has been provided with appropriate authority.

Reviewer identities will not be disclosed publicly or to authors when the applicable review model requires reviewer anonymity, except with the reviewer’s explicit agreement or when disclosure is required by law or a formal research-integrity investigation.

4. Sharing of Personal Data

Access to personal data is restricted to persons and organisations that require the information to perform legitimate journal functions.

Personal data may be shared with:

The Editor-in-Chief
Managing Editors and Journal Managers
Section Editors
Reviewers
Statistical, technical, ethics, or specialist editors
Copyeditors, layout editors, and proofreaders
Authorised Universitas Udayana or JUPI personnel
OJS administrators and technical-support personnel
Website hosting, email, security, backup, analytics, or preservation service providers
DOI registration agencies
Indexing and abstracting services
Digital repositories and library systems
Publication-ethics or research-integrity bodies when necessary
Government, regulatory, judicial, or law-enforcement authorities when disclosure is legally required

Only the information reasonably necessary for the relevant purpose will be shared.

5. Manuscript Confidentiality

Submitted manuscripts, review reports, editorial correspondence, and unpublished research information are treated as confidential.

Editors, reviewers, and other persons involved in the editorial process must not:

Disclose unpublished manuscript content without authorisation
Use unpublished information for personal or professional advantage
Share confidential files with unauthorised persons
Upload manuscripts, review reports, identifiable patient information, or confidential research data to public generative-AI systems or other unauthorised external services

Confidential information may be disclosed where necessary to investigate suspected misconduct, protect patient safety, comply with legal obligations, or obtain confidential specialist advice.

6. Research-Participant and Patient Information

Authors must not submit unnecessary personally identifiable research-participant or patient information.

Manuscripts containing case descriptions, clinical images, recordings, pedigrees, or other potentially identifiable material must comply with the IJAMI informed-consent and patient-privacy requirements.

Where identifiable patient material is necessary for publication, authors must obtain appropriate written consent for publication and must upload or retain the required documentation according to journal instructions.

Consent documents and other sensitive records will not be made publicly available unless publication is legally authorised and explicitly required.

7. Cookies and Website Technologies

The OJS platform may use cookies or similar technologies to:

Maintain authenticated user sessions
Remember language or interface preferences
Support website navigation
Protect the platform against misuse
Collect aggregate usage information
Improve system performance

Users may restrict cookies through their browser settings. Disabling essential cookies may prevent account login, manuscript submission, or other website functions from operating correctly.

Where third-party analytics or embedded services are used, those services may process technical information in accordance with their own privacy policies.

8. Data Retention

Personal data will be retained only for as long as reasonably necessary for the purpose for which they were collected, subject to scholarly-record, research-integrity, institutional, contractual, technical, and legal requirements.

Published articles and their essential bibliographic metadata are retained permanently as part of the scholarly record.

Editorial records associated with accepted, rejected, withdrawn, corrected, or retracted submissions may be retained when necessary to:

Document editorial decisions
Maintain the integrity of peer review
Resolve disputes or appeals
Investigate publication misconduct
Prevent duplicate submission
Satisfy institutional or legal requirements
Preserve an accurate publication history

Inactive account information may be deleted or anonymised when it is no longer required, subject to technical and legal limitations.

9. Data Security

IJAMI and the administrators of the Universitas Udayana OJS platform take reasonable administrative, organisational, and technical measures to protect personal data against:

Unauthorised access
Accidental loss
Misuse
Alteration
Disclosure
Destruction
Cybersecurity incidents

Access to editorial and administrative information is restricted according to assigned OJS roles and operational responsibilities.

No internet-based system can guarantee absolute security. Users are responsible for protecting their account credentials and should notify the journal promptly if they suspect unauthorised access to their account.

10. User Rights

Subject to applicable law and legitimate scholarly-publishing requirements, users may request:

Information about the personal data processed about them
Access to their personal data
Correction of inaccurate or incomplete information
Updating of their user profile
Withdrawal of consent where processing is based on consent
Deletion or anonymisation of information that is no longer required
Restriction of certain processing activities
Objection to processing in appropriate circumstances
A copy of relevant personal data in an appropriate format
Information about a suspected personal-data breach affecting them

Some requests may be limited when retaining information is necessary to protect the integrity of peer review, preserve the scholarly record, comply with legal obligations, investigate misconduct, or exercise or defend legal claims.

Requests concerning published article metadata will be handled through the journal’s correction, retraction, and scholarly-record policies rather than by deleting the publication record.

11. International Services and Metadata Distribution

Scholarly-publication metadata may be transmitted to or accessed by DOI registration agencies, indexing services, repositories, preservation networks, libraries, search engines, and other scholarly infrastructure located outside Indonesia.

Public article metadata may be copied, harvested, indexed, preserved, and redistributed internationally in accordance with the journal’s open-access and licensing policies.

Confidential manuscript and account information will not be transferred to external services except where necessary for legitimate journal operations and subject to appropriate safeguards.

12. Email Communications

IJAMI may use registered email addresses to send:

Account-verification messages
Submission acknowledgments
Editorial correspondence
Reviewer invitations and reminders
Editorial decisions
Copyediting and proof notifications
Publication announcements
Important journal or policy notices

Users may manage optional notifications through their account settings where that functionality is available. Operational messages required to process an active submission, review, or editorial assignment cannot normally be disabled while the activity remains active.

13. Third-Party Links

The IJAMI website may contain links to third-party websites, services, repositories, or indexing platforms.

IJAMI is not responsible for the privacy, security, or content practices of external websites. Users should review the privacy policies of those services before providing personal information.

14. Changes to This Privacy Statement

IJAMI may revise this Privacy Statement when journal practices, legal requirements, institutional policies, or technical systems change.

The current version and effective date will be published on the journal website. Material changes may also be communicated to registered users where appropriate.

15. Privacy Contact

Questions, correction requests, access requests, or concerns regarding personal-data processing should be directed to:

Editorial Office
Indonesian Journal of Augmented Medical Intelligence
Universitas Udayana, Bali, Indonesia
Email: ijamiudayana@unud.ac.id

For technical matters concerning the central OJS platform, requests may be referred to the authorised Universitas Udayana website administrator or information-technology unit.

Complaints concerning personal-data processing may also be submitted through the applicable institutional or governmental mechanisms under Indonesian law.